BioCentury
ARTICLE | Company News

Management tracks: Novartis, Aileron

May 16, 2018 10:57 PM UTC

Novartis AG (NYSE:NVS; SIX:NOVN) said General Counsel Felix Ehrat will retire, effective June 1, in light of Novartis' payments to a consultancy owned by Michael Cohen. "As a co-signatory with our former CEO, I take personal responsibility to bring the public debate on this matter to an end," he said in a statement. He will be succeeded by Chief Ethics, Risk and Compliance Officer Shannon Thyme Klinger (see BioCentury Extra, May 9).

Stapled peptide company Aileron Therapeutics Inc. (NASDAQ:ALRN) said President and CEO Joseph Yanchik has resigned. He is succeeded by John Longenecker as interim CEO. Longenecker was president and CEO at HemaQuest Pharmaceuticals Inc., which became Viracta Therapeutics Inc. (San Diego, Calif.)...